ArticleScientific reports2021

The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages.

Wenyun Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.